Tinzaparin Injectable Solution

DRUG2 trials

Sponsors

University Hospital, Linkoeping, Queen Mary University of London

Conditions

Epithelial Ovarian CancerInjury LegThrombosis

Phase 2

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

RecruitingNCT05284552

University Hospital, LinkoepingEpithelial Ovarian Cancer

Start: 2022-07-12End: 2027-12-01Target: 40Updated: 2026-05-11

Phase 3

Thromboprophylaxis in Lower Limb Immobilisation

RecruitingNCT06370273

Queen Mary University of LondonInjury Leg, Thrombosis

Start: 2024-11-12End: 2028-08-31Target: 10044Updated: 2026-07-02